Eagle Pharmaceuticals Inc. (EGRX) 60.53 $EGRX Eagle

New Post Public Reply Private Reply Replies (0) Message Board

Apr 22, 2015 at 11:21 PM

Eagle Pharmaceuticals Inc. (EGRX) 60.53 $EGRX

Eagle Pharmaceuticals to Present at Deutsche Bank 40th Annual Health Care Conference
Business Wire - Wed Apr 22, 3:30PM CDT
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) announced today that Scott Tarriff, President and Chief Executive Officer, and David Riggs, Chief Financial Officer, will present at the Deutsche Bank 40th Annual Health Care Conference as follows:
DB: 33.95 (+0.61), EGRX: 60.53 (+1.22)

Eagle Pharmaceuticals: Even After 350% Rally, Shares Have Upside
Bret Jensen - at Seeking Alpha - Wed Apr 22, 11:33AM CDT

EGRX: 60.53 (+1.22)

Will Eagle Pharmaceuticals (EGRX) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 6:31AM CDT
Will Eagle Pharmaceuticals (EGRX) Continue to Surge Higher?
EGRX: 60.53 (+1.22)

3 Top Healthcare Stocks Surging Higher This Year
Todd Campbell, The Motley Fool - Motley Fool - Sat Apr 18, 11:03AM CDT
Aging baby boomers and an increasingly insured population are driving healthcare utilization higher, and that has made stocks in this industry some of the market's best performers over the past three years. A number of healthcare stocks are soaring...
ESPR: 100.53 (-2.60), AZN: 73.35 (+0.65), HZNP: 30.96 (+0.10), TEVA: 63.01 (-1.15), EGRX: 60.53 (+1.22), HPTX: 45.96 (-0.18)

High Potency Recovery Supplements Combined with Increased Global Distribution Channels & New Branding Partnerships Fuels Growth Potential in the Pharmaceutical & Nutritional Supplement Industries
PR Newswire - Wed Apr 15, 7:35AM CDT
For consumers wanting to use supplements to improve their nutrition and sport performance through pharmaceutical and nutritional supplements usage plans, pharma grade products and supplements made with high-quality ingredients become top concern along with compliance and FDA regulations. Specialty pharmaceutical & Nutritional Supplement Companies in focus today are: Axxess Pharma Inc. (OTC: AXXE), GNC Holdings, Inc. (NYSE: GNC), Vitamin Shoppe (NYSE: VSI), Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and BioLife Solutions (NASDAQ: BLFS)
VSI: 44.50 (+5.54), GNC: 47.56 (+1.60), TEVA: 63.01 (-1.15), EGRX: 60.53 (+1.22), BLFS: 2.01 (-0.01)

Teva and Eagle Pharmaceuticals reports US FDA accepts the rapid infusion bendamustine NDA for review for both CLL and indolent B-cell NHL
M2 - Wed Apr 15, 5:45AM CDT
Pharmaceutical company Teva Pharmaceutical Industries (NYSE:TEVA)(TASE:TEVA Eagle Pharmaceuticals (NasdaqGM:EGRX) on Tuesday jointly revealed that the New Drug Application (NDA) for a liquid bendamustine hydrochloride (HCl) rapid infusion product has been accepted for filing by the US Food and Drug Administration (FDA).
TEVA: 63.01 (-1.15), EGRX: 60.53 (+1.22)

Nasdaq stocks posting largest percentage increases
AP - Tue Apr 14, 4:58PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
HTBX: 7.71 (-0.64), DOVR: 8.42 (-0.02), STCK: 18.52 (-0.02), CLVS: 85.04 (-1.36), ORMP: 7.25 (-0.10), BIND: 7.01 (-0.30), EGRX: 60.53 (+1.22), VLTC: 15.14 (-1.04), BCLI: 4.29 (-0.09), REPH: 10.71 (-0.78)

FDA accepts Eagle Pharma's NDA for rapid infusion bendamustine
Seeking Alpha - at Seeking Alpha - Tue Apr 14, 8:32AM CDT

TEVA: 63.01 (-1.15), EGRX: 60.53 (+1.22)

Teva and Eagle Pharmaceuticals Announce NDA for Bendamustine Rapid Infusion Product Accepted for Filing
Business Wire - Tue Apr 14, 7:00AM CDT
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) today announce that the New Drug Application (NDA) for a liquid bendamustine hydrochloride (HCl) rapid infusion product has been accepted for filing by the U.S. Food and Drug Administration (FDA). The Prescription Drug User Fee Act (PDUFA) goal date for a decision on this NDA by the FDA is December 2015.
TEVA: 63.01 (-1.15), EGRX: 60.53 (+1.22)

Eagle Pharmaceuticals hires David M. Pernock to board
M2 - Tue Apr 14, 5:39AM CDT
Pharmaceutical company Eagle Pharmaceuticals (NasdaqGM:EGRX) revealed on Monday the appointment of David M. Pernock to its board of directors.
EGRX: 60.53 (+1.22)

Eagle Pharmaceuticals Appoints David M. Pernock to Its Board of Directors
Business Wire - Mon Apr 13, 7:00AM CDT
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) ("Eagle" or "the Company"

, today announced that David M. Pernock, an experienced biotechnology and pharmaceutical executive with over 25 years of industry experience, has been appointed to its Board of Directors effective immediately.
EGRX: 60.53 (+1.22)

Eagle Pharmaceuticals receives new low-sodium Bendamustine patent in the US
M2 - Wed Apr 08, 6:44AM CDT
Pharmaceutical company Eagle Pharmaceuticals (NasdaqGM: EGRX) reported on Tuesday the receipt of the United States Patent and Trademark Office's (USPTO) patent for the use of rapid infusion bendamustine for treating patients requiring restricted fluid and/or sodium intake.
EGRX: 60.53 (+1.22)

Teva Pharmaceutical: There Is A Lot To Like About This Stock
Musings of a Banker - at Seeking Alpha - Tue Apr 07, 11:45AM CDT

ACT: 295.22 (+0.69), MYL: 72.40 (-1.67), TEVA: 63.01 (-1.15), LLY: 72.30 (+0.09), ASPX: 100.79 (+0.09), ABBV: 64.52 (+0.91), EGRX: 60.53 (+1.22), BMY: 66.60 (-0.21)

Eagle Pharmaceuticals Announces New Patent for Low-Sodium Bendamustine
Business Wire - Tue Apr 07, 9:51AM CDT
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) ("Eagle" or the "Company"

today announced that the United States Patent and Trademark Office ("USPTO"

has granted Patent No. 9,000,021 for the use of bendamustine for treating patients requiring restricted fluid and/or sodium intake. The patent issued today expires in March 2033.
EGRX: 60.53 (+1.22)

Eagle Pharmaceuticals to Present at Needham & Company's 14th Annual Healthcare Conference
Business Wire - Thu Apr 02, 3:30PM CDT
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) announced today that Scott Tarriff, President and Chief Executive Officer, and David Riggs, Chief Financial Officer, will present at Needham & Company's 14th Annual Healthcare Conference as follows:
EGRX: 60.53 (+1.22)

Eagle Pharmaceuticals (EGRX) in Focus: Stock Surges 10.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 02, 7:37AM CDT
Eagle Pharmaceuticals Inc. (EGRX) was a big mover last session, as the company saw its shares rise nearly 11% on the day.
SRDX: 26.57 (+0.02), EGRX: 60.53 (+1.22)

Eagle Pharmaceuticals prices public offering of common shares at USD42.00 per share
M2 - Wed Mar 18, 6:35AM CDT
Pharmaceutical company Eagle Pharmaceuticals (Nasdaq:EGRX) said on Tuesday that it has priced a public offering of 1,320,276 common stock at USD42.00 per share.
EGRX: 60.53 (+1.22)

Eagle Pharma prices equity offering
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 4:32PM CDT

EGRX: 60.53 (+1.22)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wally Disrupts Dental Industry with $25M Funding

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Duke Energy's Cost-Protection Plan Shields Ratepayers

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Decoding CarBravo-Certified vs Traditional Used Cars

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Ornellaia's 2026 Harvest: Adapting to Nature's Whims

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Vitamin Angels Drives Global Nutrition Advancements

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

EMCO's New Automated Facility Could Shake Industry

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

HelloNation Brings 'Edvertising' to NC REALTORS® Event

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Merit Expands in New York with Bold Acquisition Move

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...